The TaperGuard line of endotracheal tubes incorporates a unique, taper-shaped cuff made from polyvinylchloride that is designed to substantially reduce the risk of microaspiration, which refers to the entry of foreign material into the respiratory tract, according to the release. The TaperGuard Evac endotracheal tube additionally provides for secretion drainage through an integrated suction lumen and has been associated with a reduction in ventilator-associated pneumonia.
The TaperGuard Evac endotracheal tube combines the TaperGuard cuff with Mallinckrodt Evac technology, which offers secretion management capabilities by enabling continuous or intermittent drainage of secretions that collect above the cuff.
“The global launch of the TaperGuard line of endotracheal tubes illustrates Covidien’s commitment to developing innovative, proven solutions for commonly occurring healthcare complications, with the goal of decreasing patient mortality, as well as healthcare costs,” Pete Wehrly, president of respiratory and monitoring solutions for Covidien, said in the release.
Learn more about Covidien.
